Predictive factors for treatment outcomes with intravitreal anti-vascular endothelial growth factor injections in diabetic macular edema in clinical practice

RL Gurung, LM FitzGerald, E Liu, BJ McComish… - International Journal of …, 2023 - Springer
Background Intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections are the
standard of care for diabetic macular edema (DME), a common complication of diabetes …

Novel artificial intelligence algorithms for diabetic retinopathy and diabetic macular edema

J Yao, J Lim, GYS Lim, JCL Ong, Y Ke, TF Tan, TE Tan… - Eye and Vision, 2024 - Springer
Background Diabetic retinopathy (DR) and diabetic macular edema (DME) are major causes
of visual impairment that challenge global vision health. New strategies are needed to tackle …

[HTML][HTML] Association of blood pressure with incident diabetic microvascular complications among diabetic patients: Longitudinal findings from the UK Biobank

C Li, H Yu, Z Zhu, X Shang, Y Huang… - Journal of Global …, 2023 - ncbi.nlm.nih.gov
Background Evidence suggests a correlation of blood pressure (BP) level with presence of
diabetic microvascular complications (DMCs), but the effect of BP on DMCs incidence is not …

[HTML][HTML] Intravitreal injection of Conbercept combined with micropulse laser therapy enhances clinical efficacy in patients with diabetic macular edema

J Liu, R Li, K Han, X Yu, Y Tang… - American Journal of …, 2023 - ncbi.nlm.nih.gov
Purpose: To analyze the clinical efficacy of intravitreal injection of Conbercept (IVC)
combined with micropulse laser (MPL) therapy in the treatment of diabetic macular edema …

INDICADORES FÍSICO-QUÍMICOS E COMPONENTES ANTIOXIDANTES DE DUAS PLANTAS MEDICINAIS COM ALEGAÇÕES ANTIDIABÉTICAS DA AMAZÔNIA

F dos Santos Ferreira, VO Pereira… - … -ISSN 2675-6218, 2023 - recima21.com.br
O uso de plantas medicinais tem demonstrado benefícios aos pacientes com Diabetes
Mellitus do tipo 2 (DM2), incluindo a redução do estresse oxidativo, situação comum neste …